Piramal Enterprises targets to be among top 3 in OTC business: Report

14 Oct 2016 Evaluate

Piramal Enterprises is reportedly targeting to be among the top three players in the $2.2-billion over-the-counter (OTC) pharmaceutical products business in four years. At present, the company is at seventh slot.

With Rs 15,000 crore in cash and investments on the books of Piramal Enterprises, the company has already made six acquisitions for the health care business in the past two years. Three of these were made in the OTC business.

Piramal Enterprises is engaged in the business of pharmaceuticals, including research and development, financial services and information management through its subsidiaries.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers
Company Name CMP
Bajaj Finance 990.65
Shriram Finance 1008.80
Aditya Birla Capital 361.20
Chola Invest & Fin. 1780.55
Tata Capital 359.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×